deceleration in the coming year. In particular, further rises in oil will depend on whether the Islamic State of Iraq and Syria ( ISIS ) captures the oil-producing region in Southern Iraq, around Baghdad. We think this is unlikely. The headline unemployment
the Islamic State of Iraq and Syria ( ISIS ) began an offensive within Iraq to take ..... s government appear to have enabled ISIS to seize a large swath of northwest Iraq ..... presence in Mosul beforehand were critical to ISIS ’s successful march into Iraq. Expanding
Guillen. For example, attacks over the past two weeks in northern and central Iraq by the Islamic State of Iraq and the Levant ( ISIS ) have triggered widespread fears of an energy crisis in the making. Says Guillen: “Energy markets tend to be affected very
The escalating violence in Iraq and Syria is disrupting trade routes all across the Middle East, and reversing the region's past decade of growth. Supplies have either been either interrupted, or have needed to be re-routed, increasing costs in any scenario. Economic difficulties are also hitting
Isis Pharmaceuticals ( ISIS ) earns a $1M payment from alliance partner GlaxoSmithKline ( GSK ..... license, develop and commercialize the HBV treatment candidates after ISIS completes the first proof-of-concept study. ISIS is eligible to
quickly create a more politically inclusive regime. Escalating violence has led to an estimated 2,417 Iraqis killed in June, as ISIS insurgents continue to overrun many cities and regions within the country. Portugal will offer a new 10-year U.S. dollar
create a more politically inclusive regime. Escalating violence has led to an estimated 2,417 Iraqis killed in June, as ISIS insurgents continue to overrun many cities and regions within the country. ETFs: GULF , MES Post your comment!
After reading the comments on my initial article on Isis ( ISIS ), I thought it might be interesting to try to address ..... some of the recurring arguments below. Argument #1 - ISIS technology is good because they have big pharma partners
ISIS Pharmaceuticals ( ISIS ) -5.7% AH after a negative article by SA contributor Market Doc says the poor long-term safety and tolerability of ISIS ' cholesterol reducing drug Kynamro may affect the company's entire
Top gainers, as of 5:15 p.m.: AWRE +13.6% . MTW +11.9% . PRGS +8.9% . NKE +3.2% . ETE +2.4% . Top losers, as of 5:15 p.m.: ISIS -5.4% . SFM -2.7% . IG -2.3% . DD -2.2% . CTRP -1.5% . Post your comment!